Provided By GlobeNewswire
Last update: Aug 12, 2024
Company continues to make significant progress towards disrupting the existing cochlear implant industry with its investigational, breakthrough fully implanted Acclaim® cochlear implant; Maintains goal of starting Pivotal Clinical Trial by end of the year
NASDAQ:COCH (2/21/2025, 8:10:29 PM)
1.48
-0.04 (-2.89%)
Find more stocks in the Stock Screener